...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM

That's funny. I took a quick look through Sedar and yeah, no voting results. I would have thought it was an exchange requirement, even on the OTC.

That said, any shareholder is entitled to review the minutes of meetings, and the vote should be there. If you were so inclined, you could make a request to the company's legal counsel (BLG); they'd probably have you go into their office to check physically.

Share
New Message
Please login to post a reply